Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma

Background.   Diffuse gliomas represent over 80% of malignant brain tumors ranging from low-grade to aggressive high-grade lesions. Within isocitrate dehydrogenase (IDH)-mutant gliomas, there is a high variability in survival and a need to more accurately predict outcome. - Methods.   To identify an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mamatjan, Yasin (VerfasserIn) , Voisin, Mathew R (VerfasserIn) , Nassiri, Farshad (VerfasserIn) , Moraes, Fabio Y (VerfasserIn) , Bunda, Severa (VerfasserIn) , So, Jonathan (VerfasserIn) , Salih, Mira (VerfasserIn) , Shirahata, Mitsuaki (VerfasserIn) , Ono, Takahiro (VerfasserIn) , Shimizu, Hiroaki (VerfasserIn) , Schrimpf, Daniel (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Aldape, Kenneth D (VerfasserIn) , Zadeh, Gelareh (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 July 2023
In: Neuro-Oncology
Year: 2023, Jahrgang: 25, Heft: 11, Pages: 2028-204
ISSN:1523-5866
DOI:10.1093/neuonc/noad126
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noad126
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/article/25/11/2028/7227261
Volltext
Verfasserangaben:Yasin Mamatjan, Mathew R Voisin, Farshad Nassiri, Fabio Y Moraes, Severa Bunda, Jonathan So, Mira Salih, Mitsuaki Shirahata, Takahiro Ono, Hiroaki Shimizu, Daniel Schrimpf, Andreas von Deimling, Kenneth D Aldape, and Gelareh Zadeh

MARC

LEADER 00000caa a2200000 c 4500
001 1902701836
003 DE-627
005 20241205172444.0
007 cr uuu---uuuuu
008 240917s2023 xx |||||o 00| ||eng c
024 7 |a 10.1093/neuonc/noad126  |2 doi 
035 |a (DE-627)1902701836 
035 |a (DE-599)KXP1902701836 
035 |a (OCoLC)1475311745 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mamatjan, Yasin  |e VerfasserIn  |0 (DE-588)1342238796  |0 (DE-627)1902703324  |4 aut 
245 1 0 |a Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma  |c Yasin Mamatjan, Mathew R Voisin, Farshad Nassiri, Fabio Y Moraes, Severa Bunda, Jonathan So, Mira Salih, Mitsuaki Shirahata, Takahiro Ono, Hiroaki Shimizu, Daniel Schrimpf, Andreas von Deimling, Kenneth D Aldape, and Gelareh Zadeh 
264 1 |c 20 July 2023 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.09.2024 
520 |a Background.   Diffuse gliomas represent over 80% of malignant brain tumors ranging from low-grade to aggressive high-grade lesions. Within isocitrate dehydrogenase (IDH)-mutant gliomas, there is a high variability in survival and a need to more accurately predict outcome. - Methods.   To identify and characterize a predictive signature of outcome in gliomas, we utilized an integrative molecular analysis (using methylation, mRNA, copy number variation (CNV), and mutation data), analyzing a total of 729 IDH-mutant samples including a test set of 99 from University Health Network (UHN) and 2 validation cohorts including the German Cancer Research Center (DKFZ) and The Cancer Genome Atlas (TCGA). - Results.   Cox regression analysis of methylation data from the UHN cohort identified CpG-based signatures that split the glioma cohort into 2 prognostic groups strongly predicting survival that were validated using 2 independent cohorts from TCGA and DKFZ (all P-values < .0001). The methylation signatures that predicted poor outcomes also exhibited high CNV instability and hypermethylation of HOX gene probes. Integrated multi-platform analyses using mRNA and methylation (iRM) showed that parallel HOX gene overexpression and simultaneous hypermethylation were significantly associated with increased mutational load, high aneuploidy, and worse survival (P-value < .0001). A 7-HOX gene signature was developed and validated using the most significantly associated HOX genes with patient outcome in both 1p/19q codeleted and non-codeleted IDHmut gliomas. - Conclusions.   HOX gene methylation and expression provide important prognostic information in IDH-mutant gliomas that are not captured by current molecular diagnostics. A 7-HOX gene signature of outcome shows significant survival differences in both 1p/19q codeleted and non-codeleted IDH-mutant gliomas. 
700 1 |a Voisin, Mathew R  |e VerfasserIn  |4 aut 
700 1 |a Nassiri, Farshad  |e VerfasserIn  |4 aut 
700 1 |a Moraes, Fabio Y  |e VerfasserIn  |4 aut 
700 1 |a Bunda, Severa  |e VerfasserIn  |4 aut 
700 1 |a So, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Salih, Mira  |e VerfasserIn  |4 aut 
700 1 |a Shirahata, Mitsuaki  |e VerfasserIn  |4 aut 
700 1 |a Ono, Takahiro  |e VerfasserIn  |4 aut 
700 1 |a Shimizu, Hiroaki  |e VerfasserIn  |4 aut 
700 1 |a Schrimpf, Daniel  |d 1984-  |e VerfasserIn  |0 (DE-588)1063355044  |0 (DE-627)812332032  |0 (DE-576)422629529  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Aldape, Kenneth D  |e VerfasserIn  |4 aut 
700 1 |a Zadeh, Gelareh  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Neuro-Oncology  |d Oxford : Oxford Univ. Press, 1999  |g 25(2023), 11 vom: Nov., Seite 2028-204  |h Online-Ressource  |w (DE-627)357167341  |w (DE-600)2094060-9  |w (DE-576)318041839  |x 1523-5866  |7 nnas  |a Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma 
773 1 8 |g volume:25  |g year:2023  |g number:11  |g month:11  |g pages:2028-204  |g extent:14  |a Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma 
856 4 0 |u https://doi.org/10.1093/neuonc/noad126  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/neuro-oncology/article/25/11/2028/7227261  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240917 
993 |a Article 
994 |a 2023 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 12 
998 |g 1063355044  |a Schrimpf, Daniel  |m 1063355044:Schrimpf, Daniel  |d 910000  |d 912000  |e 910000PS1063355044  |e 912000PS1063355044  |k 0/910000/  |k 1/910000/912000/  |p 11 
999 |a KXP-PPN1902701836  |e 4580422473 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"20 July 2023"}],"name":{"displayForm":["Yasin Mamatjan, Mathew R Voisin, Farshad Nassiri, Fabio Y Moraes, Severa Bunda, Jonathan So, Mira Salih, Mitsuaki Shirahata, Takahiro Ono, Hiroaki Shimizu, Daniel Schrimpf, Andreas von Deimling, Kenneth D Aldape, and Gelareh Zadeh"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1902701836","id":{"doi":["10.1093/neuonc/noad126"],"eki":["1902701836"]},"person":[{"given":"Yasin","family":"Mamatjan","role":"aut","display":"Mamatjan, Yasin"},{"given":"Mathew R","display":"Voisin, Mathew R","family":"Voisin","role":"aut"},{"given":"Farshad","family":"Nassiri","role":"aut","display":"Nassiri, Farshad"},{"given":"Fabio Y","display":"Moraes, Fabio Y","role":"aut","family":"Moraes"},{"display":"Bunda, Severa","role":"aut","family":"Bunda","given":"Severa"},{"family":"So","role":"aut","display":"So, Jonathan","given":"Jonathan"},{"family":"Salih","role":"aut","display":"Salih, Mira","given":"Mira"},{"role":"aut","family":"Shirahata","display":"Shirahata, Mitsuaki","given":"Mitsuaki"},{"display":"Ono, Takahiro","family":"Ono","role":"aut","given":"Takahiro"},{"role":"aut","family":"Shimizu","display":"Shimizu, Hiroaki","given":"Hiroaki"},{"given":"Daniel","family":"Schrimpf","role":"aut","display":"Schrimpf, Daniel"},{"given":"Andreas von","display":"Deimling, Andreas von","family":"Deimling","role":"aut"},{"given":"Kenneth D","role":"aut","family":"Aldape","display":"Aldape, Kenneth D"},{"family":"Zadeh","role":"aut","display":"Zadeh, Gelareh","given":"Gelareh"}],"language":["eng"],"note":["Gesehen am 17.09.2024"],"title":[{"title":"Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma","title_sort":"Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma"}],"physDesc":[{"extent":"14 S."}],"relHost":[{"note":["Gesehen am 21.07.23"],"pubHistory":["1.1999 -"],"language":["eng"],"id":{"issn":["1523-5866"],"zdb":["2094060-9"],"eki":["357167341"]},"recId":"357167341","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant gliomaNeuro-Oncology","origin":[{"publisher":"Oxford Univ. Press ; Duke University Medical Center","publisherPlace":"Oxford ; Durham, NC","dateIssuedKey":"1999","dateIssuedDisp":"1999-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Neuro-Oncology","title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology"}],"part":{"volume":"25","text":"25(2023), 11 vom: Nov., Seite 2028-204","extent":"14","issue":"11","year":"2023","pages":"2028-204"}}]} 
SRT |a MAMATJANYAINTEGRATED2020